SE7701187L - Nya piperazinderivat och sett att framstella desamma - Google Patents

Nya piperazinderivat och sett att framstella desamma

Info

Publication number
SE7701187L
SE7701187L SE7701187A SE7701187A SE7701187L SE 7701187 L SE7701187 L SE 7701187L SE 7701187 A SE7701187 A SE 7701187A SE 7701187 A SE7701187 A SE 7701187A SE 7701187 L SE7701187 L SE 7701187L
Authority
SE
Sweden
Prior art keywords
produce
way
same
piperazine derivatives
new piperazine
Prior art date
Application number
SE7701187A
Other languages
English (en)
Swedish (sv)
Inventor
R Cyrus
M Raschack
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of SE7701187L publication Critical patent/SE7701187L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7701187A 1976-02-07 1977-02-03 Nya piperazinderivat och sett att framstella desamma SE7701187L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
SE7701187L true SE7701187L (sv) 1977-08-08

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701187A SE7701187L (sv) 1976-02-07 1977-02-03 Nya piperazinderivat och sett att framstella desamma

Country Status (25)

Country Link
US (1) US4079137A (fr)
JP (1) JPS52105186A (fr)
AT (1) AT355578B (fr)
AU (1) AU504526B2 (fr)
BE (1) BE850492A (fr)
CA (1) CA1094560A (fr)
CH (1) CH631448A5 (fr)
CS (1) CS201544B2 (fr)
DD (1) DD128133A5 (fr)
DE (1) DE2604845A1 (fr)
DK (1) DK138891C (fr)
ES (1) ES455691A1 (fr)
FI (1) FI63226C (fr)
FR (1) FR2340311A1 (fr)
GB (1) GB1550545A (fr)
HU (1) HU173483B (fr)
IE (1) IE44339B1 (fr)
IL (1) IL51316A (fr)
LU (1) LU76706A1 (fr)
NL (1) NL7700841A (fr)
NO (1) NO142625C (fr)
PL (1) PL105526B1 (fr)
PT (1) PT66154B (fr)
SE (1) SE7701187L (fr)
ZA (1) ZA77248B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
WO2006062917A2 (fr) * 2004-12-06 2006-06-15 Sciclone Pharmaceuticals, Inc. Peptides d'alpha thymosine en tant qu'adjuvants de vaccin anti-cancereux
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
WO2009075813A1 (fr) * 2007-12-12 2009-06-18 Sciclone Pharmaceuticals, Inc. Traitement d'un mélanome avec des peptides d'alpha-thymosine en association avec des anticorps contre l'antigène 4 associé au lymphocyte t cytotoxique (ctla4)
WO2009076587A1 (fr) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Traitement de mélanome par des peptides d'alpha thymosine en association avec un inhibiteur de kinase
JP2011506467A (ja) * 2007-12-14 2011-03-03 サイクローン・ファーマシューティカルズ・インコーポレイテッド 抗悪性腫瘍性熱ショックアポトーシス活性化因子（ｈｓａａ）と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
JP2012526149A (ja) * 2009-05-08 2012-10-25 サイクローン・ファーマシューティカルズ・インコーポレイテッド ワクチン増強剤としてのαチモシンペプチド
CN107148279B (zh) 2014-10-21 2021-09-03 赛生药品股份国际有限公司 用免疫刺激剂治疗癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines

Also Published As

Publication number Publication date
FI63226B (fi) 1983-01-31
CS201544B2 (en) 1980-11-28
FR2340311B1 (fr) 1980-02-08
IL51316A0 (en) 1977-03-31
NO142625C (no) 1980-09-17
IE44339L (en) 1977-08-07
FI770398A7 (fr) 1977-08-08
DK49077A (da) 1977-08-08
US4079137A (en) 1978-03-14
DD128133A5 (de) 1977-11-02
PL105526B1 (pl) 1979-10-31
NO142625B (no) 1980-06-09
CH631448A5 (de) 1982-08-13
NL7700841A (nl) 1977-08-09
ATA68177A (de) 1979-08-15
PT66154B (fr) 1978-07-07
JPS52105186A (en) 1977-09-03
DK138891B (da) 1978-11-13
ZA77248B (en) 1977-11-30
PT66154A (fr) 1977-03-01
IE44339B1 (en) 1981-10-21
IL51316A (en) 1980-12-31
AT355578B (de) 1980-03-10
DK138891C (da) 1979-04-23
CA1094560A (fr) 1981-01-27
FI63226C (fi) 1983-05-10
DE2604845A1 (de) 1977-08-18
HU173483B (hu) 1979-05-28
GB1550545A (en) 1979-08-15
AU504526B2 (en) 1979-10-18
BE850492A (fr) 1977-07-18
LU76706A1 (fr) 1977-06-28
ES455691A1 (es) 1978-01-01
AU2195277A (en) 1978-08-10
NO770374L (no) 1977-08-09
FR2340311A1 (fr) 1977-09-02

Similar Documents

Publication Publication Date Title
SE8402549D0 (sv) Substituerade moranolinderivat
SE425715B (sv) Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdom
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
NL190160C (nl) Piperazinecarboxamide- en -carbothioamidederivaten, werkwijze ter bereiding daarvan, alsmede farmaceutisch preparaat dat een dergelijk derivaat omvat.
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
SE7707462L (sv) Forfarande for framstellning av penicillansyraderivat
SE416298B (sv) Forfarande for framstellning av nya bensimidazolinon derivat
PT69582A (fr) Nouveaux acides lactame-n-acetiques et leurs amides leurs procedes de preparation et compositions pharmaceutiques
SE7705143L (sv) Nya omega-aminokarboxylsyraamider jemte sett for deras framstellning
DK148183A (da) Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
SE7608691L (sv) Forfarande for framstellning av tienopyridinderivat
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
GB1492528A (en) Pyrazinyl piperazine derivatives
SE7901493L (sv) Nya amidderivat av 5-pyrimidin-karbonsyror och sett for deras framstellning och anvendning som lekemedel
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7411243L (fr)
SE7811455L (sv) 2-imino-imidazolidin-derivat
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
NO167978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
SE8005687L (sv) Nya 10-halogen-e-homoeburnaner jemte sett for deras framstellning
DK486879A (da) Fremgangsmaade til fremstilling af aminopropanolderivater af 6-hydroxy-2,3,4,5-tetrahydro-1h-1-benzazepin-2-on eller syreadditionssalte deraf
SE420489B (sv) Forfarande for framstellning av nya substituerade 2-fenylaminoimidazoliner-(2) och ett deras syraadditionssalter
SE7701186L (sv) Alkylendioxidpiperazinderivat och sett att framstella desamma
NO792389L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylamino-imidazolin-derivater
ES440208A1 (es) Procedimiento para la fabricacion de derivados de piperazi- na.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7701187-2

Format of ref document f/p: F